logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-10. Age distributions and primary drug distributions — EU summary of clients entering treatment, 2007 or most recent year available [see all tables in this series...]

Part (v) New inpatient clients, age distribution by primary drug (%)

Substance<1515–1920–2425–2930–3435–3940–4445+Mean ageAge known (base)Age not known
Opioids0.24.725.030.818.210.75.64.829.743088
Cocaine0.36.018.929.220.811.68.15.030.46143
Stimulants1.026.330.619.89.06.23.04.025.712574
Hypnotics and sedatives2.27.39.911.79.08.610.141.240.24544
Hallucinogens6.760.020.06.70.00.06.70.020.6150
Volatile substances25.946.813.48.53.51.50.00.519.02010
Cannabis 1.529.224.619.510.76.23.34.926.015535
Other substances 1.38.422.018.115.410.14.420.333.92270
Total1.313.724.225.114.89.05.16.928.9862924

Notes:

 The countries supplying data are: 

 BG, CZ, DK, DE, IE, EL, FR, CY, LV, AT, RO, SK, FI, SE, UK, HR, TR.   

 The number of treatment clients in each country is listed in Table TDI-7

 See also Table TDI-104 on distribution by country and ‘General notes for interpreting data’ on the Explanatory notes and help page

Sources:

 Reitox national reports 2008 — Table TDI outpatient and inpatient treatment centres. 

(see the help page for information about formats etc.)

Page last updated: Tuesday, 30 June 2009